Suppr超能文献

颅内动静脉畸形相关脑动脉瘤的血管内治疗。

Endovascular treatment of cerebral aneurysms associated with arteriovenous malformations.

机构信息

Beijing Neurosurgical Institute and Beijing Tiantan Hospital, Capital Medical University, Beijing, PR China.

出版信息

Eur J Radiol. 2012 Jun;81(6):1296-8. doi: 10.1016/j.ejrad.2011.03.061. Epub 2011 Apr 13.

Abstract

BACKGROUND AND PURPOSE

In univariate survival analysis, coexisting aneurysms was associated with a significantly increased risk of hemorrhage in AVMs. We report here on our clinical experience with AVMs associated with arterial aneurysms that were managed by endovascular treatment.

METHODS

To determine the incidence of associated aneurysms, the authors reviewed 366 consecutive patients with AVMs managed between 1999 and 2009. In 86 (23.5%) of these 366 patients, 55 intranidal aneurysms and 40 proximal aneurysms were observed. Targeted endovascular treatment with coils, n-butylcyanoacrylate(NBCA) and Onyx was performed for patients in this series, using a standard protocol. We reviewed the treatment plans, radiological findings and clinical courses of 86 patients suffering AVM associated with aneurysm.

RESULTS

Ninety-five aneurysms in 86 patients with AVMs were enrolled in this study. Hemorrhage was the most frequent presenting symptom (69 patients, 80.2%). Bleeding was caused by an AVM nidus in 44 cases, aneurysm rupture in 20 and an undetermined origin in 5. Four patients were treated for associated aneurysm with coils followed by AVM embolization and 82 patients were treated with NBCA or Onyx embolization. There were total of 3 complications (3.5%) clinically significant complications in this series. Excellent or good outcomes (Glasgow Outcome Scale ≥ 4) were observed in 63 (73.3%) patients at discharge. Neurological deficits (Glasgow Outcome Scale 1-4) were 16.6% at discharge.

CONCLUSION

Endovascular treatment can be adequately used for cerebral aneurysms associated with AVMs as an adjunct to microsurgery and radiosurgery.

摘要

背景与目的

在单变量生存分析中,共存的动脉瘤与 AVM 出血的风险显著增加相关。我们在此报告我们对接受血管内治疗的伴发动脉瘤的 AVM 的临床经验。

方法

为了确定伴发动脉瘤的发生率,作者回顾了 1999 年至 2009 年间治疗的 366 例连续 AVM 患者。在这 366 例患者中,有 86 例(23.5%)观察到 55 个颅内动脉瘤和 40 个近端动脉瘤。对本系列患者采用线圈、正丁基氰基丙烯酸酯(NBCA)和 Onyx 进行靶向血管内治疗,使用标准方案。我们回顾了 86 例伴发动脉瘤的 AVM 患者的治疗计划、影像学发现和临床过程。

结果

95 个动脉瘤在 86 例 AVM 患者中被纳入本研究。出血是最常见的首发症状(69 例,80.2%)。出血是由 AVM 病灶引起的 44 例,动脉瘤破裂引起的 20 例,原因不明的 5 例。4 例患者因伴发动脉瘤而行线圈治疗,随后行 AVM 栓塞治疗,82 例患者行 NBCA 或 Onyx 栓塞治疗。本系列中共有 3 例(3.5%)并发症为临床显著并发症。出院时 63 例(73.3%)患者的预后良好(格拉斯哥预后量表≥4)。出院时神经功能缺损(格拉斯哥预后量表 1-4)为 16.6%。

结论

血管内治疗可作为显微手术和放射外科的辅助手段,充分用于伴发 AVM 的脑动脉瘤。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验